|
시장보고서
상품코드
1417394
HbA1c 검사 시장 보고서 : 동향, 예측, 경쟁 분석(-2030년)HbA1c Testing Market Report: Trends, Forecast and Competitive Analysis to 2030 |
||||||
Lucintel
HbA1c 검사 동향과 예측
세계의 HbA1c 검사 시장 규모는 2024년부터 2030년까지 CAGR 12.5%로 성장하여 2030년까지 약 34억 달러에 달할 것으로 예측됩니다. 이 시장의 주요 성장 촉진요인은 당뇨병 이환율 증가와 혈당 컨트롤에 관한 인식 확산입니다. 세계의 HbA1c 검사 시장의 미래는 병원·클리닉, 진단 검사기관, 재택의료, 연구기관 각 시장의 기회에 의해 유망해 보입니다.
HbA1c 검사 시장 인사이트
Lucintel의 예측에 따르면, 정확한 결과를 얻을 수 있고 비용 효율도 높은 비탁 저해 면역측정법은, 예측기간 동안 가장 높은 성장이 전망됩니다.
이 시장에서는 노년 인구 증가에 의해 병원·진료소가 최대 부문으로 남을 것으로 생각됩니다.
연구나 인식 제고 캠페인 등의 활동 증가에 의해 예측기간 중에도 최대 지역으로 남을 것으로 생각됩니다.
자주 묻는 질문
Q1. 시장 규모는?
A1. 세계의 HbA1c 검사 시장은 2030년까지 약 34억 달러에 달할 것으로 예상됩니다.
Q2. 시장 성장 예측은?
A2. 세계의 HbA1c 검사 시장은 2024년부터 2030년까지 CAGR 12.5%로 성장할 것으로 예측됩니다.
Q3. 시장의 성장에 영향을 미치는 주요 성장 촉진요인은?
A3. 이 시장의 주요 성장 촉진요인은 당뇨병 이환율 증가와 혈당 컨트롤에 관한 인식 확산입니다.
Q4. 시장의 주요 부문은?
A4. HbA1c 검사 시장 전망은 병원·진료소, 진단 실험실, 재택의료, 연구기관 각 시장의 기회에 의해 유망해 보입니다.
Q5. 시장의 주요 기업은?
A5. HbA1c 검사의 주요 기업은 다음과 같습니다.
- Abbott
- Bio-Rad Laboratories
- ARKRAY
- Danaher
- F. Hoffmann-La Roche
Q6. 향후 최대가 되는 시장 부문은?
A6. Lucintel의 예측에 따르면, 정확한 결과를 얻을 수 있어 비용 효율도 높은 비탁저해 면역측정법이, 예측기간 동안 가장 높은 성장을 이룰 전망입니다.
Q7. 시장에서 향후 5년 동안 최대가 될 것으로 예상되는 지역은?
A7. 북미는 이 지역의 연구나 인식 제고 캠페인 등의 활동 증가에 의해 예측기간 중에도 최대 지역으로 남을 것으로 생각됩니다.
Q8. 보고서 커스터마이징이 가능?
A8. 네, Lucintel은 추가 비용 없이 10% 커스터마이징을 제공합니다.
목차
제1장 주요 요약
제2장 세계의 HbA1c 검사 시장 : 시장 역학
- 서론, 배경, 분류
- 공급망
- 업계 성장 촉진요인과 과제
제3장 시장 동향과 예측 분석(2018-2030년)
- 거시경제 동향(2018-2023년)과 예측(2024-2030년)
- 세계의 HbA1c 검사 시장 동향(2018-2023년)과 예측(2024-2030년)
- 세계의 HbA1c 검사 시장 : 유형별
- 기기
- 시약
- 키트
- 세계의 HbA1c 검사 시장 : 기술별
- 이온 교환 HPLC
- 효소 어세이
- 친화성 결합 크로마토그래피
- 비탁저해 면역측정법
- 기타
- 세계의 HbA1c 검사 시장 : 최종 용도별
- 병원·진료소
- 진단 연구소
- 홈케어
- 연구기관
- 기타
제4장 시장 동향과 예측 분석 : 지역별(2018-2030년)
- 세계의 HbA1c 검사 시장 : 지역별
- 북미
- 유럽
- 아시아태평양
- 기타 지역
제5장 경쟁 분석
- 제품 포트폴리오 분석
- 운영상 통합
- Porter's Five Forces 분석
제6장 성장 기회와 전략적 분석
- 성장 기회 분석
- 유형별
- 기술별
- 최종 용도별
- 지역별
- 세계의 HbA1c 검사 시장 최신 동향
- 전략적 분석
- 신제품 개발
- 세계의 HbA1c 검사 시장 능력 확대
- 세계의 HbA1c 검사 시장 합병, 인수, 합작투자
- 인증과 라이선싱
제7장 유력 기업의 기업 개요
- Abbott
- Bio-Rad Laboratories
- ARKRAY
- Danaher
- F. Hoffmann-La Roche
HbA1c Testing Trends and Forecast
The future of the global HbA1c testing market looks promising with opportunities in the hospital &clinic, diagnostic laboratorie, homecare, and research institution markets. The global HbA1c testing market is expected to reach an estimated $3.4 billion by 2030 with a CAGR of 12.5% from 2024 to 2030. The major drivers for this market are growing incidence of diabetes and increasing awareness regarding glycemic control.
A more than 150-page report is developed to help in your business decisions.
HbA1c Testing by Segment
The study includes a forecast for the global HbA1c testing by type, technology, end use, and region.
HbA1c Testing Market by Type [Shipment Analysis by Value from 2018 to 2030]:
- Instruments
- Reagents
- Kits
HbA1c Testing Market by Technology [Shipment Analysis by Value from 2018 to 2030]:
- Ion-Exchange HPLC
- Enzymatic Assay
- Affinity Binding Chromatography
- Turbidimetric Inhibition Immunoassay
- Others
HbA1c Testing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
- Hospitals and Clinics
- Diagnostic Laboratories
- Homecare
- Research Institution
- Others
HbA1c Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of HbA1c Testing Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies HbA1c testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the HbA1c testing companies profiled in this report include-
- Abbott
- Bio-Rad Laboratories
- ARKRAY
- Danaher
- F. Hoffmann-La Roche
HbA1c Testing Market Insights
Lucintel forecasts that turbidimetric inhibition immunoassay is expected to witness the highest growth over the forecast period as it delivers accurate results and are cost effective.
Within this market, hospital & clinic will remain the largest segment due to growing geriatric population.
North America will remain the largest region over the forecast period due to increase in number of activities like esearch and awareness campaigns in the region.
Features of the Global HbA1c Testing Market
Market Size Estimates: HbA1c testing market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: HbA1c testing market size by type, technology, end use, and region in terms of value ($B).
Regional Analysis: HbA1c testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, technologies, end uses, and regions for the HbA1c testing market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the HbA1c testing market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the HbA1c testing market size?
Answer: The global HbA1c testing market is expected to reach an estimated $3.4 billion by 2030.
Q2. What is the growth forecast for HbA1c testing market?
Answer: The global HbA1c testing market is expected to grow with a CAGR of 12.5% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the HbA1c testing market?
Answer: The major drivers for this market are growing incidence of diabetes and increasing awareness regarding glycemic control.
Q4. What are the major segments for HbA1c testing market?
Answer: The future of the HbA1c testing market looks promising with opportunities in the hospital &clinic, diagnostic laboratory, homecare, and research institution markets.
Q5. Who are the key HbA1c testing market companies?
Answer: Some of the key HbA1c testing companies are as follows.
- Abbott
- Bio-Rad Laboratories
- ARKRAY
- Danaher
- F. Hoffmann-La Roche
Q6. Which HbA1c testing market segment will be the largest in future?
Answer: Lucintel forecasts that turbidimetric inhibition immunoassay is expected to witness the highest growth over the forecast period as it delivers accurate results and are cost effective.
Q7. In HbA1c testing market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to increase in number of activities like esearch and awareness campaigns in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
- Q.1. What are some of the most promising, high-growth opportunities for the HbA1c testing market by type (instruments, reagents, and kits), technology (ion exchange HPLC, enzymatic assay, affinity binding chromatography, turbidimetric inhibition immunoassay, and others), end use (hospitals and clinics, diagnostic laboratories, homecare, research institution, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
- Q.2. Which segments will grow at a faster pace and why?
- Q.3. Which region will grow at a faster pace and why?
- Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
- Q.5. What are the business risks and competitive threats in this market?
- Q.6. What are the emerging trends in this market and the reasons behind them?
- Q.7. What are some of the changing demands of customers in the market?
- Q.8. What are the new developments in the market? Which companies are leading these developments?
- Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
- Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
- Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
Table of Contents
1. Executive Summary
2. Global HbA1c Testing Market : Market Dynamics
- 2.1: Introduction, Background, and Classifications
- 2.2: Supply Chain
- 2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
- 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
- 3.2. Global HbA1c Testing Market Trends (2018-2023) and Forecast (2024-2030)
- 3.3: Global HbA1c Testing Market by Type
- 3.3.1: Instruments
- 3.3.2: Reagents
- 3.3.3: Kits
- 3.4: Global HbA1c Testing Market by Technology
- 3.4.1: Ion Exchange HPLC
- 3.4.2: Enzymatic assay
- 3.4.3: Affinity Binding Chromatography
- 3.4.4: Turbidimetric Inhibition Immunoassay
- 3.4.5: Others
- 3.5: Global HbA1c Testing Market by End Use
- 3.5.1: Hospitals and Clinics
- 3.5.2: Diagnostic Laboratories
- 3.5.3: Homecare
- 3.5.4: Research Institution
- 3.5.5: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
- 4.1: Global HbA1c Testing Market by Region
- 4.2: North American HbA1c Testing Market
- 4.2.1: North American HbA1c Testing Market by Technology: Ion Exchange HPLC, Enzymatic assay, Affinity Binding Chromatography, Turbidimetric Inhibition Immunoassay, and Others
- 4.2.2: North American HbA1c Testing Market by End Use: Hospitals and Clinics, Diagnostic Laboratories, Homecare, Research Institution, and Others
- 4.3: European HbA1c Testing Market
- 4.3.1: European HbA1c Testing Market by Technology: Ion Exchange HPLC, Enzymatic assay, Affinity Binding Chromatography, Turbidimetric Inhibition Immunoassay, and Others
- 4.3.2: European HbA1c Testing Market by End Use: Hospitals and Clinics, Diagnostic Laboratories, Homecare, Research Institution, and Others
- 4.4: APAC HbA1c Testing Market
- 4.4.1: APAC HbA1c Testing Market by Technology: Ion Exchange HPLC, Enzymatic assay, Affinity Binding Chromatography, Turbidimetric Inhibition Immunoassay, and Others
- 4.4.2: APAC HbA1c Testing Market by End Use: Hospitals and Clinics, Diagnostic Laboratories, Homecare, Research Institution, and Others
- 4.5: ROW HbA1c Testing Market
- 4.5.1: ROW HbA1c Testing Market by Technology: Ion Exchange HPLC, Enzymatic assay, Affinity Binding Chromatography, Turbidimetric Inhibition Immunoassay, and Others
- 4.5.2: ROW HbA1c Testing Market by End Use: Hospitals and Clinics, Diagnostic Laboratories, Homecare, Research Institution, and Others
5. Competitor Analysis
- 5.1: Product Portfolio Analysis
- 5.2: Operational Integration
- 5.3: Porter's Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
- 6.1: Growth Opportunity Analysis
- 6.1.1: Growth Opportunities for the Global HbA1c Testing Market by Type
- 6.1.2: Growth Opportunities for the Global HbA1c Testing Market by Technology
- 6.1.3: Growth Opportunities for the Global HbA1c Testing Market by End Use
- 6.1.4: Growth Opportunities for the Global HbA1c Testing Market by Region
- 6.2: Emerging Trends in the Global HbA1c Testing Market
- 6.3: Strategic Analysis
- 6.3.1: New Product Development
- 6.3.2: Capacity Expansion of the Global HbA1c Testing Market
- 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global HbA1c Testing Market
- 6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
- 7.1: Abbott
- 7.2: Bio-Rad Laboratories
- 7.3: ARKRAY
- 7.4: Danaher
- 7.5: F. Hoffmann-La Roche
